Sudeep Pharma Ltd
NSE: SUDEEPPHRM | BSE: 544619
₹665.00
As on 21-May-2026 10:44IST
Market cap
₹7,342 Cr
Revenue (TTM)
₹502 Cr
P/E Ratio
52.9
P/B Ratio
8.5
Div. Yield
0 %
Quality Score
10/10
Growth Score
6/10
Valuation Score
3/10
Momentum Score
UNRATED/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹139 Cr
-
ROE
32.8 %
-
ROCE
35.8 %
-
Industry P/E
40.29
-
EV/EBITDA
37
-
Debt to Equity
0.3
-
Book Value
₹50.5
-
EPS
₹14.3
-
Face value
1
-
Shares outstanding
112,948,625
10 Years Aggregate
CFO
₹98.87 Cr
EBITDA
₹650.12 Cr
Net Profit
₹469.12 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sudeep Pharma
| 10.3 | 0.1 | 0.0 | -- | -- | -- | -- |
|
BSE Healthcare
| 10.1 | 10.2 | 11.0 | 13.3 | 28.0 | 14.4 | 12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sudeep Pharma
|
665.0 | 7,341.7 | 502.0 | 138.7 | -- | 32.8 | 52.9 | 8.5 |
| 1,069.6 | 13,003.0 | 2,551.8 | 564.5 | 28.3 | 18.4 | 23 | 3.9 | |
| 443.4 | 7,588.3 | 1,053.1 | 293.6 | 32.3 | 24.6 | 25.8 | 5.9 | |
| 1,121.2 | 11,670.5 | 1,158.7 | 309.6 | 31.9 | 17.3 | 37.3 | 6.2 | |
| 1,725.7 | 32,846.4 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.5 | 6.6 | |
| 356.0 | 3,883.5 | 159.3 | 47.8 | 39.0 | 18.6 | 81.3 | 14.0 | |
| 16,623.0 | 21,331.6 | 2,023.0 | 364.0 | 23.9 | 20.8 | 58.6 | 11.4 | |
| 2,295.7 | 3,808.9 | 707.5 | 115.2 | 17.8 | 19.4 | 33.1 | -- | |
| 1,127.4 | 4,987.4 | 649.5 | 121.6 | 23.7 | 13.2 | 43.2 | 5.3 | |
| 272.5 | 7,090.1 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 12.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsAbout Sudeep Pharma
--
-
Incorporated
1989
-
Chairman
Sujit Jaysukh Bhayani
-
Managing Director
Sujit Jaysukh Bhayani
-
Headquarters
Vadodara, Gujarat
-
Website
Looking for more details about Sudeep Pharma Ltd’s IPO? Explore our IPO Details page.
Quarterly Updates
FAQs for Sudeep Pharma
What is the current share price of Sudeep Pharma Ltd Today?
The share price of Sudeep Pharma Ltd is ₹665.00 (NSE) and ₹666.00 (BSE) as of 21-May-2026 10:44 IST. Sudeep Pharma Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Sudeep Pharma Ltd?
The P/E ratio of Sudeep Pharma Ltd is 52.94 times as on 20-May-2026, a 31 premium to its peers’ median range of 40.29 times.
The P/B ratio of Sudeep Pharma Ltd is 8.45 times as on 20-May-2026, a 110 premium to its peers’ median range of 4.03 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Sudeep Pharma Ltd?
The 52-week high and low of Sudeep Pharma Ltd are Rs 795.00 and Rs 524.05 as of 21-May-2026.
What is the market cap of Sudeep Pharma Ltd?
Sudeep Pharma Ltd has a market capitalisation of ₹ 7,342 Cr as on 20-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sudeep Pharma Ltd?
Before investing in Sudeep Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
